Find therapies in clinical trials near you – page 677

Study on Amantadine Hemisulfate for Patients with Unresponsive Wakefulness Syndrome in Intensive and Intermediate Care Units

Study on the Effects and Safety of INZ-701 for Children with ENPP1 Deficiency

Study on the Effects and Safety of INZ-701 for Children with ENPP1 Deficiency

Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study on Elinzanetant for Treating Sleep Disturbances in Menopausal Women

Study on Elinzanetant for Treating Sleep Disturbances in Menopausal Women

Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Study on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer

Study on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer